Brain 18fluorodeoxyglucose-positron emission tomography changes in amyotrophic lateral sclerosis with TARDBP mutations

Brain ¹⁸fluorodeoxyglucose-positron emission tomography changes in amyotrophic lateral sclerosis with TARDBP mutations

J Neurol Neurosurg Psychiatry. 2022 Sep;93(9):1021-1023. doi: 10.1136/jnnp-2021-328296. Epub 2022 Mar 29.

Antonio Canosa^{1

2

3}, Andrea Calvo^{4

2

5}, Cristina Moglia^{4

2}, Rosario Vasta⁴, Francesca Palumbo⁴, Giuseppe Fuda⁴, Francesca Di Pede⁴, Sara Cabras⁴, Vincenzo Arena⁶, Andrea Novara⁴, Paolina Salamone⁴, Enrico Matteoni⁴, Luca Sbaiz⁷, Salvatore Gallone², Maurizio Grassano⁴, Umberto Manera^{4

2}, Adriano Chiò^#^{4

2

3

5}, Marco Pagani^#^{3

8}

¹ ALS Centre, 'Rita Levi Montalcini' Department of Neuroscience, University of Turin, Turin, Italy antonio.canosa@unito.it.
² SC Neurologia 1U, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, Turin, Italy.
³ Institute of Cognitive Sciences and Technologies, C.N.R, Rome, Italy.
⁴ ALS Centre, 'Rita Levi Montalcini' Department of Neuroscience, University of Turin, Turin, Italy.
⁵ Neuroscience Institute of Turin (NIT), Turin, Italy.
⁶ Positron Emission Tomography Centre AFFIDEA-IRMET S.p.A, Turin, Italy.
⁷ Laboratory of Genetics, Department of Clinical Pathology, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, Turin, Italy.
⁸ Department of Medical Radiation Physics and Nuclear Medicine, Karolinska University Hospital, Stockholm, Sweden.

^# Contributed equally.

No abstract available

Keywords: ALS; CEREBRAL METABOLISM; FUNCTIONAL IMAGING; NUCLEAR MEDICINE; PET.